Exclusive: Life Sciences Investor Briefing - Destiny Pharma #DEST, Shield #STX & Open Orphan #ORPH Watch Now
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Jay 12. . Have we got a deicaited seller on the team , someone whom has the experience to bring deals home ?
Wrong board sorry , Pharmaceutical bunch
Firstly posting a Strong Buy , allow me in my own particular way to explain why .
As a LTH , you become jaded , FOMO , in love with what can be a cruel Mistress .
Sometimes a new set of eyes help as tunnel vision can also be a part of being a LTH .
So let’s assume we are at work discussing investments , you mention HURRICANE.
You have the length of time it takes a member of the public to sell themselves on The Dragons Den , or a Player Silk Cut !
So to me there is No Better Time To Invest in Hurricane.
So where do we start !
I have got 7 reasons why , ranging from very recent world events to significant data from around the world that specialise in Out Type Of Play .
So what else , what’s rejuvenated my interest in Hurricane ?
What's odd about challenging assmptions? I was invested and I may reinvest. I don't understand your ire, a little over the top?
When will you be reinvested in NFX?
I think that states a lot don’t you. Posting constantly on a share you currently apparently sold out of?
There are some seriously manipulative people on investor bulletin boards. How often they post and when - and what. Is it objective, is it consistently objective or could it be in their interest for some reason other than belief in the company to ramp a share up when it's going down and they know it's going down (albeit temporarily). I think we know the answer to that.
Thank you for your reply. I do, as I keep saying, fully appreciate the potential here. I'm waiting on hard fact before acting myself.
indivestor I agree was a bitter twisted poster (from Milton Keynes, I think that says it all IMO).. Been banned hear and the other sites for his strange posts..
Did not know he was scaryone..
Good posts New..... good to see you back !
NXP001 and NSB...
While I understand PI concerns. The reality is that NSB were chosen as we (our chairman) have had, many many years (10 plus) doing deals with them. Ie better the devil you know.
Yatai are (who bought out NSB) a much more traditional set up. (prob wanted NSB drug pipelines/fresh approach)
If there was a problem apart from say, licenses to Yatai or NSB.Paper work in China re cocrystal(we are the first). There can be no contract issues as we have passed the milestones in the contracts.
So IF NFX wanted to. It could re license elsewhere.. Find another partner (one more modern and probably a lot bigger/better suited to us)
I as a LTH am not concerned. It is taking longer than we all assumed (inc Dan!)
China is a small part of the world. There are many other countries that want NXP001 and Pharma companies .
So the absolute downside is we license it to another Chinese company for a better deal..(if there was a problem)
Upside there is more money and a better partner.
Now IF there was a problem over anything on our side. We would of known(as company duty bound to inform us). So the harsh reality is that there is delays. Delays in language and delays in paper work/translation/Chinese regs etc. That or maybe NSB want NXP002 as well. It could be one of many many things. But what it can not be is the results/contract.. As we have passed a highly regulated test (human trials).
The Chinese are renowned as late payers, boot leggers and hard to work with..
The rest of the world is not... That is where we will earn the real money.. Not a few mill from NSB
Great informative first post!
u again bore off
I do struggle to understand.
When I was reading this bulletin board I do remember that poster Indivestor who was rude, impatient and sold out entirely saying June before anything would happen. He then got removed for posting abusive posts? I don’t remember it how you say. Strange that,
Aim4utopia was positive about the company for years and he was right. Those that bought before March made a hefty amount on their investment.
I really don’t understand the problem.
I think the little egos should be left in the playground with their rocket toys.
Obsessive behaviour is not healthy and I suggest you stick to the company.
Nobody cares about your personal issues I’m afraid and you really should get help with it.
who might you be...
I am an investor here for the long term.....and also an observer of who posts what when and how often...
hope that answers your question
Why would that be and also who might you be. Interesting all these names here posting complete utter carp but supposedly support the investment they continue to try hurt. What a strange scenario?
I think most see who you are :)
.....Member Info for Newhorizon
(Last 30 Days)
re....Unfortunately he is not silenced as continues as Scarryone and NewHorizon but most people like you say are wise to him now. What a nasty piece of work.
15th Sep 2019
31st AUGUST 2019........ahhh I see now....through a glass darkly etc etc....
13 Sep '19 - 09:18 - 2407 of 2408
0 0 0
I am just glad that LSE finally banned him and am very happy that it was in response to my reporting. I reported a post and next day admin had banned and deleted his posts. A victory of sorts.
Unfortunately he is not silenced as continues as Scarryone and NewHorizon but most people like you say are wise to him now. What a nasty piece of work.
I speak as an active holder of the stock.
If I had sold I would not spend all my time posting on a share I do not hold.
That’s my point your point is irrelevant in regards to what I was talking about.
Many many folk on here with so many agendas at play Hey!!!
I personally don’t care what you think in the slightest so filter me.
But I do care about the company I’m invested in. I dislike folk who post to try create negative debate.
If you want facts listen to Dan’s interview and await news. Otherwise it’s people being people. Jealous, greed etc Human nature.
I buy out of my own convictions and research and I think most do unless your a trader trying to catch a tail of something you know nothing on.
I’m invested and happily invested. Will be much happier soon
Without new of payment the shares is gonna stay at 5-7p range.
Rampers ( paid or not ) can say what they want but no diligent investor will be relaxed until the above happens!!
The share price is where it is for a reason , nothing at all due to what people post on here. I for one welcome Albi's and all other reflective contributions that add value, balance and perspective.
The last few interviews since July, Justin has asked Dan about the Chinese payment and each time Dan says it close to being resolved. Until it is resolved that shadow hangs over us and all potential or actual investors. Maybe you want Justin to be silenced for asking the questions that are utmost in most investors minds at the moment.
Let's hope it is resolved quickly and the result is positive for the Company and shareholders but please don't deride others when it is the situation that is the problem.
Well if the Chinese renage on payment ,who else will want to deal with them .
Hoping for payment soon to regain confidence
This one sorry.
“The positive results from the trial now enable the Company to:
· Confirm NXP001's potential for development as a treatment for CINV, enabling current and future licensees to launch new products into the £16bn oncology supportive care market
· Trigger a final milestone payment of £2m from its Chinese licensing partner, Newsummit Biopharma, who have commenced product registration in China (Nuformix retains 10% royalty, with remaining milestone payments expected during June 2019)
· Progress on-going discussions for licensing rest of world rights to NXP001 for CINV
· Finalise further product development opportunities for the NXP001 programme to generate additional future value
· Progress its wider portfolio using the Company's proven approach in identifying high-value applications for cocrystal technology
You have been posting on this bulletin board for the last few weeks like a person possessed yet you sold out etc etc.
I find it strange that you don’t even understand that NXP001 has passed all trials and is technically passed stage three drug ready to be packaged up by the companies who take it on and sold as a drug used all around the world to prevent CINV. What bit of derisked in that fact do you not understand.
“Nuformix' first clinical study for NXP001 completed on 22 April 2019 in a cross-over study that aimed to measure the relative bioavailability of NXP001 compared to Merck's EMEND® in healthy subjects. All enrolled subjects completed the study and were discharged without adverse effects, with results expected by end H1 2019.
Prior to entry to the clinic, Nuformix carried out an additional studies to further validate it's prototype NXP001 cocrystal formulations. NSB's acceptance of success in this work announced today brings the total milestone payments from NSB to £1 million, with a further £2 million payment due dependant on relative human bioavailability results, as per the agreement for NXP001 marketing and distribution in China.
Commenting on the news, Dr Dan Gooding, CEO of Nuformix, said: "We're delighted to have reached this second pre-clinical milestone. The data generated was not only sufficient to trigger a second payment of £500k with NewsummitBio, but also gave us tremendous confidence to make the next step into human studies. We look forward to sharing human data very soon and continue to work closely with NSB, such is their commitment to the commercialisation of NXP001 and its understanding of the commercial opportunity in China. Milestone revenues continue to validate Nuformix's business model and its commitment to reinvest early revenues back into R&D, avoiding further fund-raising at this stage whilst maximising the potential value of its cocrystal platform."
Multi billion pound market
Alibi , its 30mill mcap and weve already got 1 drug passed through trials that we can market all over the world. Its easy to fall for a story but also all to easy to forget the huge success so far this year. I would argue this is not far derisked at current mcap.
As soon as / if we receive chinese cash this will fly back towards 10p. Listen to dans recent podcast again on vx, he always chooses his words carefully but it was full of intent about payment and i think we ll get an update on this next week.
Lot of potential here, also definitely not derisked yet. I'm already in a nailbiting stock and don't need another one at the moment but will get back in when I rebalance and things look clearer and I imagine they should in a few months time.
Not saying you may be biased particularly more an observation on my part on how easy it is to fall in love with a good story and filter out negative news.
Not biased alibi just still very confident with the long term prospects here. I have plenty of reservations im not blind to them, short term this could go either way....big sell from cpl, no cash from chinese could send this lower still but neither of those change the fact were on the brink of nxp002 trials. Wether we are 6p or 12p right now doesnt hugely matter to me as im here long term and wont be selling until we get through trials. I personally think dan and joanne deserve their salaries for many of the reasons jay gave